BIIB Income Statement
Biogen Inc - Revenue, Expenses & Profit Analysis
Stock Price
$205.99
Market Cap
$29.33B
P/E Ratio
21.4
Most Recent Quarter
Period: FY(2025-12-31)
Revenue
Total sales from operations
$9.89B
+2.2% YoY
Cost of Revenue
Direct costs of sales
$2.40B
Gross Profit
Revenue - Cost of Revenue
$7.49B
Interest Expense
Cost of debt
$267.50M
Net Income
Bottom line profit
$1.29B
Margin: 13.8%
Earnings Per Share (Diluted)
Net income per share
$8.79
Profitability Metrics
Net Margin
13.8%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| FY | $9.89B | $7.49B | - | $1.29B | $8.79 |
| 2024-12-31 | $9.68B | - | - | $1.63B | $11.18 |
| FY | $9.68B | $7.37B | - | $1.63B | $11.18 |
| 2023-12-31 | $9.84B | - | - | $1.16B | $7.97 |
| FY | $9.84B | $7.30B | - | $1.16B | $7.97 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is BIIB's revenue?
BIIB's most recent quarterly revenue was $9.89B, representing a growth of 2.2% year-over-year.
Is BIIB profitable?
BIIB reported a profit of $1.29B in the most recent quarter. The net profit margin is 13.8%.
What is BIIB's operating income?
Operating income data is available in the income statement.
What is BIIB's earnings per share (EPS)?
BIIB reported diluted earnings per share of $8.79 in the most recent quarter.
What is BIIB's gross profit margin?
Gross margin data is available in the profitability metrics section.